Boston Scientific Corp.’s appeal to reverse a 2014 transvaginal mesh verdict was declined by the federal court. A total of $18.5 million was awarded by the jury belonging to the U.S. District Court, Southern District of West Virginia to the four plaintiffs named in the litigation, who suffered serious complications following the implantation of BSC’s Obtryx transvaginal mesh devices.
BSC was successful in settling two of the cases out of court for undisclosed amounts since the trial, but it went ahead and appealed the remaining awards to the 4th U.S. Circuit Court of Appeals. This appeal was denied as the Appeals Court disagreed with the company’s contentions, finding that Boston Scientific had failed to provide any evidence of prejudice or confusion.